SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-010090
Filing Date
2014-02-14
Accepted
2014-02-14 08:05:48
Documents
8
Period of Report
2014-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-5247_98k.htm 8-K 34790
2 EX-1.1 a14-5247_9ex1d1.htm EX-1.1 587733
3 EX-5.1 a14-5247_9ex5d1.htm EX-5.1 13689
4 EX-99.1 a14-5247_9ex99d1.htm EX-99.1 17001
5 EX-99.2 a14-5247_9ex99d2.htm EX-99.2 17640
6 GRAPHIC g52479mmi001.gif GRAPHIC 3296
7 GRAPHIC g52477kqi001.jpg GRAPHIC 2224
8 GRAPHIC g52479moi001.jpg GRAPHIC 2847
  Complete submission text file 0001104659-14-010090.txt   684036
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 14610561
SIC: 2834 Pharmaceutical Preparations